new indications for glp 1 drugs Oral semaglutide (Rybelsus) is the 4th GLP-1 receptor agonist formulation to receive FDA approval to reduce the risk of major cardiovascular events in patients with type 2 diabetes. Our GLP-1 Agonist chart Can one drug do it
Description
Semaglutide medications work by mimicking increased levels of a hormone called GLP-1 (glucagon-like peptide 1), a satiety signal that slows digestion and makes us feel full
Individual variation in response Average weight loss numbers obscure tremendous individual variation
Cost Another consideration is cost
doi: 10.1503/cmaj.191707
Grutzik, R
